Global Neurological Biomarkers Market Growth 2025-2031
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Neurological Biomarkers market size is predicted to grow from US$ 8498 million in 2025 to US$ 17180 million in 2031; it is expected to grow at a CAGR of 12.4% from 2025 to 2031.
A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.
Global Neurological Biomarkers key players include Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, etc. Global top four manufacturers hold a share about 25%.
North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, Proteomics is the largest segment, with a share about 30%. And in terms of application, the largest application is Proteomics, followed by Drug Discovery, Personalized Medicine, etc.
LP Information, Inc. (LPI) ' newest research report, the “Neurological Biomarkers Industry Forecast” looks at past sales and reviews total world Neurological Biomarkers sales in 2024, providing a comprehensive analysis by region and market sector of projected Neurological Biomarkers sales for 2025 through 2031. With Neurological Biomarkers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurological Biomarkers industry.
This Insight Report provides a comprehensive analysis of the global Neurological Biomarkers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurological Biomarkers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurological Biomarkers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurological Biomarkers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurological Biomarkers.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurological Biomarkers market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Neurological Biomarkers market?
What factors are driving Neurological Biomarkers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neurological Biomarkers market opportunities vary by end market size?
How does Neurological Biomarkers break out by Type, by Application?
The global Neurological Biomarkers market size is predicted to grow from US$ 8498 million in 2025 to US$ 17180 million in 2031; it is expected to grow at a CAGR of 12.4% from 2025 to 2031.
A biomarker is a characteristic that can be objectively measured and evaluated as an indicator of a physiological as well as a pathological process or pharmacological response to a therapeutic intervention. Examples of classical biomarkers are measurable alterations in blood pressure and blood glucose in diabetes mellitus.
Global Neurological Biomarkers key players include Thermo Fisher Scientific, Merck, Quest Diagnostics, Abbott, etc. Global top four manufacturers hold a share about 25%.
North America is the largest market, with a share over 55%, followed by Europe, and Asia-Pacific, both have a share over 35 percent.
In terms of product, Proteomics is the largest segment, with a share about 30%. And in terms of application, the largest application is Proteomics, followed by Drug Discovery, Personalized Medicine, etc.
LP Information, Inc. (LPI) ' newest research report, the “Neurological Biomarkers Industry Forecast” looks at past sales and reviews total world Neurological Biomarkers sales in 2024, providing a comprehensive analysis by region and market sector of projected Neurological Biomarkers sales for 2025 through 2031. With Neurological Biomarkers sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Neurological Biomarkers industry.
This Insight Report provides a comprehensive analysis of the global Neurological Biomarkers landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Neurological Biomarkers portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Neurological Biomarkers market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Neurological Biomarkers and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Neurological Biomarkers.
This report presents a comprehensive overview, market shares, and growth opportunities of Neurological Biomarkers market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Proteomics
- Genomics
- Imaging
- Bioinformatics
- Others
- Diagnostics
- Drug Discovery
- Personalized Medicine
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Thermo Fisher Scientific
- Merck
- Quest Diagnostics
- Abbott
- Roche
- Illumina
- Bio-Rad Laboratories
- QIAGEN
- Myriad RBM
- Cisbio Bioassays
- Athena Diagnostics
- BGI
- Wuxi APP
- Aepodia
- Proteome Sciences
- Genewiz
What is the 10-year outlook for the global Neurological Biomarkers market?
What factors are driving Neurological Biomarkers market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Neurological Biomarkers market opportunities vary by end market size?
How does Neurological Biomarkers break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurological Biomarkers Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Neurological Biomarkers by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Neurological Biomarkers by Country/Region, 2020, 2024 & 2031
2.2 Neurological Biomarkers Segment by Type
2.2.1 Proteomics
2.2.2 Genomics
2.2.3 Imaging
2.2.4 Bioinformatics
2.2.5 Others
2.3 Neurological Biomarkers Sales by Type
2.3.1 Global Neurological Biomarkers Sales Market Share by Type (2020-2025)
2.3.2 Global Neurological Biomarkers Revenue and Market Share by Type (2020-2025)
2.3.3 Global Neurological Biomarkers Sale Price by Type (2020-2025)
2.4 Neurological Biomarkers Segment by Application
2.4.1 Diagnostics
2.4.2 Drug Discovery
2.4.3 Personalized Medicine
2.4.4 Others
2.5 Neurological Biomarkers Sales by Application
2.5.1 Global Neurological Biomarkers Sale Market Share by Application (2020-2025)
2.5.2 Global Neurological Biomarkers Revenue and Market Share by Application (2020-2025)
2.5.3 Global Neurological Biomarkers Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Neurological Biomarkers Breakdown Data by Company
3.1.1 Global Neurological Biomarkers Annual Sales by Company (2020-2025)
3.1.2 Global Neurological Biomarkers Sales Market Share by Company (2020-2025)
3.2 Global Neurological Biomarkers Annual Revenue by Company (2020-2025)
3.2.1 Global Neurological Biomarkers Revenue by Company (2020-2025)
3.2.2 Global Neurological Biomarkers Revenue Market Share by Company (2020-2025)
3.3 Global Neurological Biomarkers Sale Price by Company
3.4 Key Manufacturers Neurological Biomarkers Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurological Biomarkers Product Location Distribution
3.4.2 Players Neurological Biomarkers Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEUROLOGICAL BIOMARKERS BY GEOGRAPHIC REGION
4.1 World Historic Neurological Biomarkers Market Size by Geographic Region (2020-2025)
4.1.1 Global Neurological Biomarkers Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Neurological Biomarkers Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Neurological Biomarkers Market Size by Country/Region (2020-2025)
4.2.1 Global Neurological Biomarkers Annual Sales by Country/Region (2020-2025)
4.2.2 Global Neurological Biomarkers Annual Revenue by Country/Region (2020-2025)
4.3 Americas Neurological Biomarkers Sales Growth
4.4 APAC Neurological Biomarkers Sales Growth
4.5 Europe Neurological Biomarkers Sales Growth
4.6 Middle East & Africa Neurological Biomarkers Sales Growth
5 AMERICAS
5.1 Americas Neurological Biomarkers Sales by Country
5.1.1 Americas Neurological Biomarkers Sales by Country (2020-2025)
5.1.2 Americas Neurological Biomarkers Revenue by Country (2020-2025)
5.2 Americas Neurological Biomarkers Sales by Type (2020-2025)
5.3 Americas Neurological Biomarkers Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurological Biomarkers Sales by Region
6.1.1 APAC Neurological Biomarkers Sales by Region (2020-2025)
6.1.2 APAC Neurological Biomarkers Revenue by Region (2020-2025)
6.2 APAC Neurological Biomarkers Sales by Type (2020-2025)
6.3 APAC Neurological Biomarkers Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neurological Biomarkers by Country
7.1.1 Europe Neurological Biomarkers Sales by Country (2020-2025)
7.1.2 Europe Neurological Biomarkers Revenue by Country (2020-2025)
7.2 Europe Neurological Biomarkers Sales by Type (2020-2025)
7.3 Europe Neurological Biomarkers Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurological Biomarkers by Country
8.1.1 Middle East & Africa Neurological Biomarkers Sales by Country (2020-2025)
8.1.2 Middle East & Africa Neurological Biomarkers Revenue by Country (2020-2025)
8.2 Middle East & Africa Neurological Biomarkers Sales by Type (2020-2025)
8.3 Middle East & Africa Neurological Biomarkers Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurological Biomarkers
10.3 Manufacturing Process Analysis of Neurological Biomarkers
10.4 Industry Chain Structure of Neurological Biomarkers
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurological Biomarkers Distributors
11.3 Neurological Biomarkers Customer
12 WORLD FORECAST REVIEW FOR NEUROLOGICAL BIOMARKERS BY GEOGRAPHIC REGION
12.1 Global Neurological Biomarkers Market Size Forecast by Region
12.1.1 Global Neurological Biomarkers Forecast by Region (2026-2031)
12.1.2 Global Neurological Biomarkers Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Neurological Biomarkers Forecast by Type (2026-2031)
12.7 Global Neurological Biomarkers Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Information
13.1.2 Thermo Fisher Scientific Neurological Biomarkers Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Thermo Fisher Scientific Main Business Overview
13.1.5 Thermo Fisher Scientific Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Neurological Biomarkers Product Portfolios and Specifications
13.2.3 Merck Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Quest Diagnostics
13.3.1 Quest Diagnostics Company Information
13.3.2 Quest Diagnostics Neurological Biomarkers Product Portfolios and Specifications
13.3.3 Quest Diagnostics Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Quest Diagnostics Main Business Overview
13.3.5 Quest Diagnostics Latest Developments
13.4 Abbott
13.4.1 Abbott Company Information
13.4.2 Abbott Neurological Biomarkers Product Portfolios and Specifications
13.4.3 Abbott Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Abbott Main Business Overview
13.4.5 Abbott Latest Developments
13.5 Roche
13.5.1 Roche Company Information
13.5.2 Roche Neurological Biomarkers Product Portfolios and Specifications
13.5.3 Roche Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Roche Main Business Overview
13.5.5 Roche Latest Developments
13.6 Illumina
13.6.1 Illumina Company Information
13.6.2 Illumina Neurological Biomarkers Product Portfolios and Specifications
13.6.3 Illumina Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Illumina Main Business Overview
13.6.5 Illumina Latest Developments
13.7 Bio-Rad Laboratories
13.7.1 Bio-Rad Laboratories Company Information
13.7.2 Bio-Rad Laboratories Neurological Biomarkers Product Portfolios and Specifications
13.7.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Bio-Rad Laboratories Main Business Overview
13.7.5 Bio-Rad Laboratories Latest Developments
13.8 QIAGEN
13.8.1 QIAGEN Company Information
13.8.2 QIAGEN Neurological Biomarkers Product Portfolios and Specifications
13.8.3 QIAGEN Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 QIAGEN Main Business Overview
13.8.5 QIAGEN Latest Developments
13.9 Myriad RBM
13.9.1 Myriad RBM Company Information
13.9.2 Myriad RBM Neurological Biomarkers Product Portfolios and Specifications
13.9.3 Myriad RBM Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Myriad RBM Main Business Overview
13.9.5 Myriad RBM Latest Developments
13.10 Cisbio Bioassays
13.10.1 Cisbio Bioassays Company Information
13.10.2 Cisbio Bioassays Neurological Biomarkers Product Portfolios and Specifications
13.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Cisbio Bioassays Main Business Overview
13.10.5 Cisbio Bioassays Latest Developments
13.11 Athena Diagnostics
13.11.1 Athena Diagnostics Company Information
13.11.2 Athena Diagnostics Neurological Biomarkers Product Portfolios and Specifications
13.11.3 Athena Diagnostics Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Athena Diagnostics Main Business Overview
13.11.5 Athena Diagnostics Latest Developments
13.12 BGI
13.12.1 BGI Company Information
13.12.2 BGI Neurological Biomarkers Product Portfolios and Specifications
13.12.3 BGI Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 BGI Main Business Overview
13.12.5 BGI Latest Developments
13.13 Wuxi APP
13.13.1 Wuxi APP Company Information
13.13.2 Wuxi APP Neurological Biomarkers Product Portfolios and Specifications
13.13.3 Wuxi APP Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Wuxi APP Main Business Overview
13.13.5 Wuxi APP Latest Developments
13.14 Aepodia
13.14.1 Aepodia Company Information
13.14.2 Aepodia Neurological Biomarkers Product Portfolios and Specifications
13.14.3 Aepodia Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Aepodia Main Business Overview
13.14.5 Aepodia Latest Developments
13.15 Proteome Sciences
13.15.1 Proteome Sciences Company Information
13.15.2 Proteome Sciences Neurological Biomarkers Product Portfolios and Specifications
13.15.3 Proteome Sciences Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Proteome Sciences Main Business Overview
13.15.5 Proteome Sciences Latest Developments
13.16 Genewiz
13.16.1 Genewiz Company Information
13.16.2 Genewiz Neurological Biomarkers Product Portfolios and Specifications
13.16.3 Genewiz Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Genewiz Main Business Overview
13.16.5 Genewiz Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Neurological Biomarkers Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Neurological Biomarkers Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Proteomics
Table 4. Major Players of Genomics
Table 5. Major Players of Imaging
Table 6. Major Players of Bioinformatics
Table 7. Major Players of Others
Table 8. Global Neurological Biomarkers Sales byType (2020-2025) & (K Units)
Table 9. Global Neurological Biomarkers Sales Market Share byType (2020-2025)
Table 10. Global Neurological Biomarkers Revenue byType (2020-2025) & ($ million)
Table 11. Global Neurological Biomarkers Revenue Market Share byType (2020-2025)
Table 12. Global Neurological Biomarkers Sale Price byType (2020-2025) & (USD/Unit)
Table 13. Global Neurological Biomarkers Sale by Application (2020-2025) & (K Units)
Table 14. Global Neurological Biomarkers Sale Market Share by Application (2020-2025)
Table 15. Global Neurological Biomarkers Revenue by Application (2020-2025) & ($ million)
Table 16. Global Neurological Biomarkers Revenue Market Share by Application (2020-2025)
Table 17. Global Neurological Biomarkers Sale Price by Application (2020-2025) & (USD/Unit)
Table 18. Global Neurological Biomarkers Sales by Company (2020-2025) & (K Units)
Table 19. Global Neurological Biomarkers Sales Market Share by Company (2020-2025)
Table 20. Global Neurological Biomarkers Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Neurological Biomarkers Revenue Market Share by Company (2020-2025)
Table 22. Global Neurological Biomarkers Sale Price by Company (2020-2025) & (USD/Unit)
Table 23. Key Manufacturers Neurological Biomarkers Producing Area Distribution and Sales Area
Table 24. Players Neurological Biomarkers Products Offered
Table 25. Neurological Biomarkers Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Neurological Biomarkers Sales by Geographic Region (2020-2025) & (K Units)
Table 29. Global Neurological Biomarkers Sales Market Share Geographic Region (2020-2025)
Table 30. Global Neurological Biomarkers Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Neurological Biomarkers Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Neurological Biomarkers Sales by Country/Region (2020-2025) & (K Units)
Table 33. Global Neurological Biomarkers Sales Market Share by Country/Region (2020-2025)
Table 34. Global Neurological Biomarkers Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Neurological Biomarkers Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Neurological Biomarkers Sales by Country (2020-2025) & (K Units)
Table 37. Americas Neurological Biomarkers Sales Market Share by Country (2020-2025)
Table 38. Americas Neurological Biomarkers Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Neurological Biomarkers Sales byType (2020-2025) & (K Units)
Table 40. Americas Neurological Biomarkers Sales by Application (2020-2025) & (K Units)
Table 41. APAC Neurological Biomarkers Sales by Region (2020-2025) & (K Units)
Table 42. APAC Neurological Biomarkers Sales Market Share by Region (2020-2025)
Table 43. APAC Neurological Biomarkers Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Neurological Biomarkers Sales byType (2020-2025) & (K Units)
Table 45. APAC Neurological Biomarkers Sales by Application (2020-2025) & (K Units)
Table 46. Europe Neurological Biomarkers Sales by Country (2020-2025) & (K Units)
Table 47. Europe Neurological Biomarkers Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Neurological Biomarkers Sales byType (2020-2025) & (K Units)
Table 49. Europe Neurological Biomarkers Sales by Application (2020-2025) & (K Units)
Table 50. Middle East & Africa Neurological Biomarkers Sales by Country (2020-2025) & (K Units)
Table 51. Middle East & Africa Neurological Biomarkers Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Neurological Biomarkers Sales byType (2020-2025) & (K Units)
Table 53. Middle East & Africa Neurological Biomarkers Sales by Application (2020-2025) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Neurological Biomarkers
Table 55. Key Market Challenges & Risks of Neurological Biomarkers
Table 56. Key IndustryTrends of Neurological Biomarkers
Table 57. Neurological Biomarkers Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Neurological Biomarkers Distributors List
Table 60. Neurological Biomarkers Customer List
Table 61. Global Neurological Biomarkers SalesForecast by Region (2026-2031) & (K Units)
Table 62. Global Neurological Biomarkers RevenueForecast by Region (2026-2031) & ($ millions)
Table 63. Americas Neurological Biomarkers SalesForecast by Country (2026-2031) & (K Units)
Table 64. Americas Neurological Biomarkers Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 65. APAC Neurological Biomarkers SalesForecast by Region (2026-2031) & (K Units)
Table 66. APAC Neurological Biomarkers Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 67. Europe Neurological Biomarkers SalesForecast by Country (2026-2031) & (K Units)
Table 68. Europe Neurological Biomarkers RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Neurological Biomarkers SalesForecast by Country (2026-2031) & (K Units)
Table 70. Middle East & Africa Neurological Biomarkers RevenueForecast by Country (2026-2031) & ($ millions)
Table 71. Global Neurological Biomarkers SalesForecast byType (2026-2031) & (K Units)
Table 72. Global Neurological Biomarkers RevenueForecast byType (2026-2031) & ($ millions)
Table 73. Global Neurological Biomarkers SalesForecast by Application (2026-2031) & (K Units)
Table 74. Global Neurological Biomarkers RevenueForecast by Application (2026-2031) & ($ millions)
Table 75.ThermoFisher Scientific Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 76.ThermoFisher Scientific Neurological Biomarkers Product Portfolios and Specifications
Table 77.ThermoFisher Scientific Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78.ThermoFisher Scientific Main Business
Table 79.ThermoFisher Scientific Latest Developments
Table 80. Merck Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 81. Merck Neurological Biomarkers Product Portfolios and Specifications
Table 82. Merck Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Merck Main Business
Table 84. Merck Latest Developments
Table 85. Quest Diagnostics Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 86. Quest Diagnostics Neurological Biomarkers Product Portfolios and Specifications
Table 87. Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Quest Diagnostics Main Business
Table 89. Quest Diagnostics Latest Developments
Table 90. Abbott Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 91. Abbott Neurological Biomarkers Product Portfolios and Specifications
Table 92. Abbott Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Abbott Main Business
Table 94. Abbott Latest Developments
Table 95. Roche Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 96. Roche Neurological Biomarkers Product Portfolios and Specifications
Table 97. Roche Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Roche Main Business
Table 99. Roche Latest Developments
Table 100. Illumina Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 101. Illumina Neurological Biomarkers Product Portfolios and Specifications
Table 102. Illumina Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Illumina Main Business
Table 104. Illumina Latest Developments
Table 105. Bio-Rad Laboratories Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 106. Bio-Rad Laboratories Neurological Biomarkers Product Portfolios and Specifications
Table 107. Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Bio-Rad Laboratories Main Business
Table 109. Bio-Rad Laboratories Latest Developments
Table 110. QIAGEN Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 111. QIAGEN Neurological Biomarkers Product Portfolios and Specifications
Table 112. QIAGEN Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. QIAGEN Main Business
Table 114. QIAGEN Latest Developments
Table 115. Myriad RBM Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 116. Myriad RBM Neurological Biomarkers Product Portfolios and Specifications
Table 117. Myriad RBM Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Myriad RBM Main Business
Table 119. Myriad RBM Latest Developments
Table 120. Cisbio Bioassays Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 121. Cisbio Bioassays Neurological Biomarkers Product Portfolios and Specifications
Table 122. Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Cisbio Bioassays Main Business
Table 124. Cisbio Bioassays Latest Developments
Table 125. Athena Diagnostics Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 126. Athena Diagnostics Neurological Biomarkers Product Portfolios and Specifications
Table 127. Athena Diagnostics Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Athena Diagnostics Main Business
Table 129. Athena Diagnostics Latest Developments
Table 130. BGI Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 131. BGI Neurological Biomarkers Product Portfolios and Specifications
Table 132. BGI Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. BGI Main Business
Table 134. BGI Latest Developments
Table 135. Wuxi APP Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 136. Wuxi APP Neurological Biomarkers Product Portfolios and Specifications
Table 137. Wuxi APP Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Wuxi APP Main Business
Table 139. Wuxi APP Latest Developments
Table 140. Aepodia Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 141. Aepodia Neurological Biomarkers Product Portfolios and Specifications
Table 142. Aepodia Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Aepodia Main Business
Table 144. Aepodia Latest Developments
Table 145. Proteome Sciences Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 146. Proteome Sciences Neurological Biomarkers Product Portfolios and Specifications
Table 147. Proteome Sciences Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Proteome Sciences Main Business
Table 149. Proteome Sciences Latest Developments
Table 150. Genewiz Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 151. Genewiz Neurological Biomarkers Product Portfolios and Specifications
Table 152. Genewiz Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Genewiz Main Business
Table 154. Genewiz Latest Developments
LIST OFFIGURES
Figure 1. Picture of Neurological Biomarkers
Figure 2. Neurological Biomarkers Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurological Biomarkers Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Neurological Biomarkers Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Neurological Biomarkers Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Neurological Biomarkers Sales Market Share by Country/Region (2024)
Figure 10. Neurological Biomarkers Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Proteomics
Figure 12. Product Picture of Genomics
Figure 13. Product Picture of Imaging
Figure 14. Product Picture of Bioinformatics
Figure 15. Product Picture of Others
Figure 16. Global Neurological Biomarkers Sales Market Share byType in 2025
Figure 17. Global Neurological Biomarkers Revenue Market Share byType (2020-2025)
Figure 18. Neurological Biomarkers Consumed in Diagnostics
Figure 19. Global Neurological Biomarkers Market: Diagnostics (2020-2025) & (K Units)
Figure 20. Neurological Biomarkers Consumed in Drug Discovery
Figure 21. Global Neurological Biomarkers Market: Drug Discovery (2020-2025) & (K Units)
Figure 22. Neurological Biomarkers Consumed in Personalized Medicine
Figure 23. Global Neurological Biomarkers Market: Personalized Medicine (2020-2025) & (K Units)
Figure 24. Neurological Biomarkers Consumed in Others
Figure 25. Global Neurological Biomarkers Market: Others (2020-2025) & (K Units)
Figure 26. Global Neurological Biomarkers Sale Market Share by Application (2024)
Figure 27. Global Neurological Biomarkers Revenue Market Share by Application in 2025
Figure 28. Neurological Biomarkers Sales by Company in 2025 (K Units)
Figure 29. Global Neurological Biomarkers Sales Market Share by Company in 2025
Figure 30. Neurological Biomarkers Revenue by Company in 2025 ($ millions)
Figure 31. Global Neurological Biomarkers Revenue Market Share by Company in 2025
Figure 32. Global Neurological Biomarkers Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Neurological Biomarkers Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Neurological Biomarkers Sales 2020-2025 (K Units)
Figure 35. Americas Neurological Biomarkers Revenue 2020-2025 ($ millions)
Figure 36. APAC Neurological Biomarkers Sales 2020-2025 (K Units)
Figure 37. APAC Neurological Biomarkers Revenue 2020-2025 ($ millions)
Figure 38. Europe Neurological Biomarkers Sales 2020-2025 (K Units)
Figure 39. Europe Neurological Biomarkers Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Neurological Biomarkers Sales 2020-2025 (K Units)
Figure 41. Middle East & Africa Neurological Biomarkers Revenue 2020-2025 ($ millions)
Figure 42. Americas Neurological Biomarkers Sales Market Share by Country in 2025
Figure 43. Americas Neurological Biomarkers Revenue Market Share by Country (2020-2025)
Figure 44. Americas Neurological Biomarkers Sales Market Share byType (2020-2025)
Figure 45. Americas Neurological Biomarkers Sales Market Share by Application (2020-2025)
Figure 46. United States Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Neurological Biomarkers Sales Market Share by Region in 2025
Figure 51. APAC Neurological Biomarkers Revenue Market Share by Region (2020-2025)
Figure 52. APAC Neurological Biomarkers Sales Market Share byType (2020-2025)
Figure 53. APAC Neurological Biomarkers Sales Market Share by Application (2020-2025)
Figure 54. China Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 58. India Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 60. ChinaTaiwan Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Neurological Biomarkers Sales Market Share by Country in 2025
Figure 62. Europe Neurological Biomarkers Revenue Market Share by Country (2020-2025)
Figure 63. Europe Neurological Biomarkers Sales Market Share byType (2020-2025)
Figure 64. Europe Neurological Biomarkers Sales Market Share by Application (2020-2025)
Figure 65. Germany Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 66.France Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Neurological Biomarkers Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Neurological Biomarkers Sales Market Share byType (2020-2025)
Figure 72. Middle East & Africa Neurological Biomarkers Sales Market Share by Application (2020-2025)
Figure 73. Egypt Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 76.Turkey Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Neurological Biomarkers in 2025
Figure 79. Manufacturing Process Analysis of Neurological Biomarkers
Figure 80. Industry Chain Structure of Neurological Biomarkers
Figure 81. Channels of Distribution
Figure 82. Global Neurological Biomarkers Sales MarketForecast by Region (2026-2031)
Figure 83. Global Neurological Biomarkers Revenue Market ShareForecast by Region (2026-2031)
Figure 84. Global Neurological Biomarkers Sales Market ShareForecast byType (2026-2031)
Figure 85. Global Neurological Biomarkers Revenue Market ShareForecast byType (2026-2031)
Figure 86. Global Neurological Biomarkers Sales Market ShareForecast by Application (2026-2031)
Figure 87. Global Neurological Biomarkers Revenue Market ShareForecast by Application (2026-2031)
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Neurological Biomarkers Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Neurological Biomarkers by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Neurological Biomarkers by Country/Region, 2020, 2024 & 2031
2.2 Neurological Biomarkers Segment by Type
2.2.1 Proteomics
2.2.2 Genomics
2.2.3 Imaging
2.2.4 Bioinformatics
2.2.5 Others
2.3 Neurological Biomarkers Sales by Type
2.3.1 Global Neurological Biomarkers Sales Market Share by Type (2020-2025)
2.3.2 Global Neurological Biomarkers Revenue and Market Share by Type (2020-2025)
2.3.3 Global Neurological Biomarkers Sale Price by Type (2020-2025)
2.4 Neurological Biomarkers Segment by Application
2.4.1 Diagnostics
2.4.2 Drug Discovery
2.4.3 Personalized Medicine
2.4.4 Others
2.5 Neurological Biomarkers Sales by Application
2.5.1 Global Neurological Biomarkers Sale Market Share by Application (2020-2025)
2.5.2 Global Neurological Biomarkers Revenue and Market Share by Application (2020-2025)
2.5.3 Global Neurological Biomarkers Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Neurological Biomarkers Breakdown Data by Company
3.1.1 Global Neurological Biomarkers Annual Sales by Company (2020-2025)
3.1.2 Global Neurological Biomarkers Sales Market Share by Company (2020-2025)
3.2 Global Neurological Biomarkers Annual Revenue by Company (2020-2025)
3.2.1 Global Neurological Biomarkers Revenue by Company (2020-2025)
3.2.2 Global Neurological Biomarkers Revenue Market Share by Company (2020-2025)
3.3 Global Neurological Biomarkers Sale Price by Company
3.4 Key Manufacturers Neurological Biomarkers Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Neurological Biomarkers Product Location Distribution
3.4.2 Players Neurological Biomarkers Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR NEUROLOGICAL BIOMARKERS BY GEOGRAPHIC REGION
4.1 World Historic Neurological Biomarkers Market Size by Geographic Region (2020-2025)
4.1.1 Global Neurological Biomarkers Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Neurological Biomarkers Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Neurological Biomarkers Market Size by Country/Region (2020-2025)
4.2.1 Global Neurological Biomarkers Annual Sales by Country/Region (2020-2025)
4.2.2 Global Neurological Biomarkers Annual Revenue by Country/Region (2020-2025)
4.3 Americas Neurological Biomarkers Sales Growth
4.4 APAC Neurological Biomarkers Sales Growth
4.5 Europe Neurological Biomarkers Sales Growth
4.6 Middle East & Africa Neurological Biomarkers Sales Growth
5 AMERICAS
5.1 Americas Neurological Biomarkers Sales by Country
5.1.1 Americas Neurological Biomarkers Sales by Country (2020-2025)
5.1.2 Americas Neurological Biomarkers Revenue by Country (2020-2025)
5.2 Americas Neurological Biomarkers Sales by Type (2020-2025)
5.3 Americas Neurological Biomarkers Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Neurological Biomarkers Sales by Region
6.1.1 APAC Neurological Biomarkers Sales by Region (2020-2025)
6.1.2 APAC Neurological Biomarkers Revenue by Region (2020-2025)
6.2 APAC Neurological Biomarkers Sales by Type (2020-2025)
6.3 APAC Neurological Biomarkers Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Neurological Biomarkers by Country
7.1.1 Europe Neurological Biomarkers Sales by Country (2020-2025)
7.1.2 Europe Neurological Biomarkers Revenue by Country (2020-2025)
7.2 Europe Neurological Biomarkers Sales by Type (2020-2025)
7.3 Europe Neurological Biomarkers Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Neurological Biomarkers by Country
8.1.1 Middle East & Africa Neurological Biomarkers Sales by Country (2020-2025)
8.1.2 Middle East & Africa Neurological Biomarkers Revenue by Country (2020-2025)
8.2 Middle East & Africa Neurological Biomarkers Sales by Type (2020-2025)
8.3 Middle East & Africa Neurological Biomarkers Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Neurological Biomarkers
10.3 Manufacturing Process Analysis of Neurological Biomarkers
10.4 Industry Chain Structure of Neurological Biomarkers
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Neurological Biomarkers Distributors
11.3 Neurological Biomarkers Customer
12 WORLD FORECAST REVIEW FOR NEUROLOGICAL BIOMARKERS BY GEOGRAPHIC REGION
12.1 Global Neurological Biomarkers Market Size Forecast by Region
12.1.1 Global Neurological Biomarkers Forecast by Region (2026-2031)
12.1.2 Global Neurological Biomarkers Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Neurological Biomarkers Forecast by Type (2026-2031)
12.7 Global Neurological Biomarkers Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Thermo Fisher Scientific
13.1.1 Thermo Fisher Scientific Company Information
13.1.2 Thermo Fisher Scientific Neurological Biomarkers Product Portfolios and Specifications
13.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Thermo Fisher Scientific Main Business Overview
13.1.5 Thermo Fisher Scientific Latest Developments
13.2 Merck
13.2.1 Merck Company Information
13.2.2 Merck Neurological Biomarkers Product Portfolios and Specifications
13.2.3 Merck Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Merck Main Business Overview
13.2.5 Merck Latest Developments
13.3 Quest Diagnostics
13.3.1 Quest Diagnostics Company Information
13.3.2 Quest Diagnostics Neurological Biomarkers Product Portfolios and Specifications
13.3.3 Quest Diagnostics Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Quest Diagnostics Main Business Overview
13.3.5 Quest Diagnostics Latest Developments
13.4 Abbott
13.4.1 Abbott Company Information
13.4.2 Abbott Neurological Biomarkers Product Portfolios and Specifications
13.4.3 Abbott Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Abbott Main Business Overview
13.4.5 Abbott Latest Developments
13.5 Roche
13.5.1 Roche Company Information
13.5.2 Roche Neurological Biomarkers Product Portfolios and Specifications
13.5.3 Roche Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Roche Main Business Overview
13.5.5 Roche Latest Developments
13.6 Illumina
13.6.1 Illumina Company Information
13.6.2 Illumina Neurological Biomarkers Product Portfolios and Specifications
13.6.3 Illumina Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Illumina Main Business Overview
13.6.5 Illumina Latest Developments
13.7 Bio-Rad Laboratories
13.7.1 Bio-Rad Laboratories Company Information
13.7.2 Bio-Rad Laboratories Neurological Biomarkers Product Portfolios and Specifications
13.7.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 Bio-Rad Laboratories Main Business Overview
13.7.5 Bio-Rad Laboratories Latest Developments
13.8 QIAGEN
13.8.1 QIAGEN Company Information
13.8.2 QIAGEN Neurological Biomarkers Product Portfolios and Specifications
13.8.3 QIAGEN Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 QIAGEN Main Business Overview
13.8.5 QIAGEN Latest Developments
13.9 Myriad RBM
13.9.1 Myriad RBM Company Information
13.9.2 Myriad RBM Neurological Biomarkers Product Portfolios and Specifications
13.9.3 Myriad RBM Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Myriad RBM Main Business Overview
13.9.5 Myriad RBM Latest Developments
13.10 Cisbio Bioassays
13.10.1 Cisbio Bioassays Company Information
13.10.2 Cisbio Bioassays Neurological Biomarkers Product Portfolios and Specifications
13.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Cisbio Bioassays Main Business Overview
13.10.5 Cisbio Bioassays Latest Developments
13.11 Athena Diagnostics
13.11.1 Athena Diagnostics Company Information
13.11.2 Athena Diagnostics Neurological Biomarkers Product Portfolios and Specifications
13.11.3 Athena Diagnostics Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Athena Diagnostics Main Business Overview
13.11.5 Athena Diagnostics Latest Developments
13.12 BGI
13.12.1 BGI Company Information
13.12.2 BGI Neurological Biomarkers Product Portfolios and Specifications
13.12.3 BGI Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 BGI Main Business Overview
13.12.5 BGI Latest Developments
13.13 Wuxi APP
13.13.1 Wuxi APP Company Information
13.13.2 Wuxi APP Neurological Biomarkers Product Portfolios and Specifications
13.13.3 Wuxi APP Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Wuxi APP Main Business Overview
13.13.5 Wuxi APP Latest Developments
13.14 Aepodia
13.14.1 Aepodia Company Information
13.14.2 Aepodia Neurological Biomarkers Product Portfolios and Specifications
13.14.3 Aepodia Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Aepodia Main Business Overview
13.14.5 Aepodia Latest Developments
13.15 Proteome Sciences
13.15.1 Proteome Sciences Company Information
13.15.2 Proteome Sciences Neurological Biomarkers Product Portfolios and Specifications
13.15.3 Proteome Sciences Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Proteome Sciences Main Business Overview
13.15.5 Proteome Sciences Latest Developments
13.16 Genewiz
13.16.1 Genewiz Company Information
13.16.2 Genewiz Neurological Biomarkers Product Portfolios and Specifications
13.16.3 Genewiz Neurological Biomarkers Sales, Revenue, Price and Gross Margin (2020-2025)
13.16.4 Genewiz Main Business Overview
13.16.5 Genewiz Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OFTABLES
Table 1. Neurological Biomarkers Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Neurological Biomarkers Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Proteomics
Table 4. Major Players of Genomics
Table 5. Major Players of Imaging
Table 6. Major Players of Bioinformatics
Table 7. Major Players of Others
Table 8. Global Neurological Biomarkers Sales byType (2020-2025) & (K Units)
Table 9. Global Neurological Biomarkers Sales Market Share byType (2020-2025)
Table 10. Global Neurological Biomarkers Revenue byType (2020-2025) & ($ million)
Table 11. Global Neurological Biomarkers Revenue Market Share byType (2020-2025)
Table 12. Global Neurological Biomarkers Sale Price byType (2020-2025) & (USD/Unit)
Table 13. Global Neurological Biomarkers Sale by Application (2020-2025) & (K Units)
Table 14. Global Neurological Biomarkers Sale Market Share by Application (2020-2025)
Table 15. Global Neurological Biomarkers Revenue by Application (2020-2025) & ($ million)
Table 16. Global Neurological Biomarkers Revenue Market Share by Application (2020-2025)
Table 17. Global Neurological Biomarkers Sale Price by Application (2020-2025) & (USD/Unit)
Table 18. Global Neurological Biomarkers Sales by Company (2020-2025) & (K Units)
Table 19. Global Neurological Biomarkers Sales Market Share by Company (2020-2025)
Table 20. Global Neurological Biomarkers Revenue by Company (2020-2025) & ($ millions)
Table 21. Global Neurological Biomarkers Revenue Market Share by Company (2020-2025)
Table 22. Global Neurological Biomarkers Sale Price by Company (2020-2025) & (USD/Unit)
Table 23. Key Manufacturers Neurological Biomarkers Producing Area Distribution and Sales Area
Table 24. Players Neurological Biomarkers Products Offered
Table 25. Neurological Biomarkers Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 26. New Products and Potential Entrants
Table 27. Market M&A Activity & Strategy
Table 28. Global Neurological Biomarkers Sales by Geographic Region (2020-2025) & (K Units)
Table 29. Global Neurological Biomarkers Sales Market Share Geographic Region (2020-2025)
Table 30. Global Neurological Biomarkers Revenue by Geographic Region (2020-2025) & ($ millions)
Table 31. Global Neurological Biomarkers Revenue Market Share by Geographic Region (2020-2025)
Table 32. Global Neurological Biomarkers Sales by Country/Region (2020-2025) & (K Units)
Table 33. Global Neurological Biomarkers Sales Market Share by Country/Region (2020-2025)
Table 34. Global Neurological Biomarkers Revenue by Country/Region (2020-2025) & ($ millions)
Table 35. Global Neurological Biomarkers Revenue Market Share by Country/Region (2020-2025)
Table 36. Americas Neurological Biomarkers Sales by Country (2020-2025) & (K Units)
Table 37. Americas Neurological Biomarkers Sales Market Share by Country (2020-2025)
Table 38. Americas Neurological Biomarkers Revenue by Country (2020-2025) & ($ millions)
Table 39. Americas Neurological Biomarkers Sales byType (2020-2025) & (K Units)
Table 40. Americas Neurological Biomarkers Sales by Application (2020-2025) & (K Units)
Table 41. APAC Neurological Biomarkers Sales by Region (2020-2025) & (K Units)
Table 42. APAC Neurological Biomarkers Sales Market Share by Region (2020-2025)
Table 43. APAC Neurological Biomarkers Revenue by Region (2020-2025) & ($ millions)
Table 44. APAC Neurological Biomarkers Sales byType (2020-2025) & (K Units)
Table 45. APAC Neurological Biomarkers Sales by Application (2020-2025) & (K Units)
Table 46. Europe Neurological Biomarkers Sales by Country (2020-2025) & (K Units)
Table 47. Europe Neurological Biomarkers Revenue by Country (2020-2025) & ($ millions)
Table 48. Europe Neurological Biomarkers Sales byType (2020-2025) & (K Units)
Table 49. Europe Neurological Biomarkers Sales by Application (2020-2025) & (K Units)
Table 50. Middle East & Africa Neurological Biomarkers Sales by Country (2020-2025) & (K Units)
Table 51. Middle East & Africa Neurological Biomarkers Revenue Market Share by Country (2020-2025)
Table 52. Middle East & Africa Neurological Biomarkers Sales byType (2020-2025) & (K Units)
Table 53. Middle East & Africa Neurological Biomarkers Sales by Application (2020-2025) & (K Units)
Table 54. Key Market Drivers & Growth Opportunities of Neurological Biomarkers
Table 55. Key Market Challenges & Risks of Neurological Biomarkers
Table 56. Key IndustryTrends of Neurological Biomarkers
Table 57. Neurological Biomarkers Raw Material
Table 58. Key Suppliers of Raw Materials
Table 59. Neurological Biomarkers Distributors List
Table 60. Neurological Biomarkers Customer List
Table 61. Global Neurological Biomarkers SalesForecast by Region (2026-2031) & (K Units)
Table 62. Global Neurological Biomarkers RevenueForecast by Region (2026-2031) & ($ millions)
Table 63. Americas Neurological Biomarkers SalesForecast by Country (2026-2031) & (K Units)
Table 64. Americas Neurological Biomarkers Annual RevenueForecast by Country (2026-2031) & ($ millions)
Table 65. APAC Neurological Biomarkers SalesForecast by Region (2026-2031) & (K Units)
Table 66. APAC Neurological Biomarkers Annual RevenueForecast by Region (2026-2031) & ($ millions)
Table 67. Europe Neurological Biomarkers SalesForecast by Country (2026-2031) & (K Units)
Table 68. Europe Neurological Biomarkers RevenueForecast by Country (2026-2031) & ($ millions)
Table 69. Middle East & Africa Neurological Biomarkers SalesForecast by Country (2026-2031) & (K Units)
Table 70. Middle East & Africa Neurological Biomarkers RevenueForecast by Country (2026-2031) & ($ millions)
Table 71. Global Neurological Biomarkers SalesForecast byType (2026-2031) & (K Units)
Table 72. Global Neurological Biomarkers RevenueForecast byType (2026-2031) & ($ millions)
Table 73. Global Neurological Biomarkers SalesForecast by Application (2026-2031) & (K Units)
Table 74. Global Neurological Biomarkers RevenueForecast by Application (2026-2031) & ($ millions)
Table 75.ThermoFisher Scientific Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 76.ThermoFisher Scientific Neurological Biomarkers Product Portfolios and Specifications
Table 77.ThermoFisher Scientific Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78.ThermoFisher Scientific Main Business
Table 79.ThermoFisher Scientific Latest Developments
Table 80. Merck Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 81. Merck Neurological Biomarkers Product Portfolios and Specifications
Table 82. Merck Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Merck Main Business
Table 84. Merck Latest Developments
Table 85. Quest Diagnostics Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 86. Quest Diagnostics Neurological Biomarkers Product Portfolios and Specifications
Table 87. Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Quest Diagnostics Main Business
Table 89. Quest Diagnostics Latest Developments
Table 90. Abbott Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 91. Abbott Neurological Biomarkers Product Portfolios and Specifications
Table 92. Abbott Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. Abbott Main Business
Table 94. Abbott Latest Developments
Table 95. Roche Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 96. Roche Neurological Biomarkers Product Portfolios and Specifications
Table 97. Roche Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Roche Main Business
Table 99. Roche Latest Developments
Table 100. Illumina Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 101. Illumina Neurological Biomarkers Product Portfolios and Specifications
Table 102. Illumina Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Illumina Main Business
Table 104. Illumina Latest Developments
Table 105. Bio-Rad Laboratories Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 106. Bio-Rad Laboratories Neurological Biomarkers Product Portfolios and Specifications
Table 107. Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 108. Bio-Rad Laboratories Main Business
Table 109. Bio-Rad Laboratories Latest Developments
Table 110. QIAGEN Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 111. QIAGEN Neurological Biomarkers Product Portfolios and Specifications
Table 112. QIAGEN Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 113. QIAGEN Main Business
Table 114. QIAGEN Latest Developments
Table 115. Myriad RBM Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 116. Myriad RBM Neurological Biomarkers Product Portfolios and Specifications
Table 117. Myriad RBM Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 118. Myriad RBM Main Business
Table 119. Myriad RBM Latest Developments
Table 120. Cisbio Bioassays Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 121. Cisbio Bioassays Neurological Biomarkers Product Portfolios and Specifications
Table 122. Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 123. Cisbio Bioassays Main Business
Table 124. Cisbio Bioassays Latest Developments
Table 125. Athena Diagnostics Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 126. Athena Diagnostics Neurological Biomarkers Product Portfolios and Specifications
Table 127. Athena Diagnostics Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 128. Athena Diagnostics Main Business
Table 129. Athena Diagnostics Latest Developments
Table 130. BGI Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 131. BGI Neurological Biomarkers Product Portfolios and Specifications
Table 132. BGI Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 133. BGI Main Business
Table 134. BGI Latest Developments
Table 135. Wuxi APP Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 136. Wuxi APP Neurological Biomarkers Product Portfolios and Specifications
Table 137. Wuxi APP Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 138. Wuxi APP Main Business
Table 139. Wuxi APP Latest Developments
Table 140. Aepodia Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 141. Aepodia Neurological Biomarkers Product Portfolios and Specifications
Table 142. Aepodia Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 143. Aepodia Main Business
Table 144. Aepodia Latest Developments
Table 145. Proteome Sciences Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 146. Proteome Sciences Neurological Biomarkers Product Portfolios and Specifications
Table 147. Proteome Sciences Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 148. Proteome Sciences Main Business
Table 149. Proteome Sciences Latest Developments
Table 150. Genewiz Basic Information, Neurological Biomarkers Manufacturing Base, Sales Area and Its Competitors
Table 151. Genewiz Neurological Biomarkers Product Portfolios and Specifications
Table 152. Genewiz Neurological Biomarkers Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 153. Genewiz Main Business
Table 154. Genewiz Latest Developments
LIST OFFIGURES
Figure 1. Picture of Neurological Biomarkers
Figure 2. Neurological Biomarkers Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Neurological Biomarkers Sales Growth Rate 2020-2031 (K Units)
Figure 7. Global Neurological Biomarkers Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Neurological Biomarkers Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Neurological Biomarkers Sales Market Share by Country/Region (2024)
Figure 10. Neurological Biomarkers Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of Proteomics
Figure 12. Product Picture of Genomics
Figure 13. Product Picture of Imaging
Figure 14. Product Picture of Bioinformatics
Figure 15. Product Picture of Others
Figure 16. Global Neurological Biomarkers Sales Market Share byType in 2025
Figure 17. Global Neurological Biomarkers Revenue Market Share byType (2020-2025)
Figure 18. Neurological Biomarkers Consumed in Diagnostics
Figure 19. Global Neurological Biomarkers Market: Diagnostics (2020-2025) & (K Units)
Figure 20. Neurological Biomarkers Consumed in Drug Discovery
Figure 21. Global Neurological Biomarkers Market: Drug Discovery (2020-2025) & (K Units)
Figure 22. Neurological Biomarkers Consumed in Personalized Medicine
Figure 23. Global Neurological Biomarkers Market: Personalized Medicine (2020-2025) & (K Units)
Figure 24. Neurological Biomarkers Consumed in Others
Figure 25. Global Neurological Biomarkers Market: Others (2020-2025) & (K Units)
Figure 26. Global Neurological Biomarkers Sale Market Share by Application (2024)
Figure 27. Global Neurological Biomarkers Revenue Market Share by Application in 2025
Figure 28. Neurological Biomarkers Sales by Company in 2025 (K Units)
Figure 29. Global Neurological Biomarkers Sales Market Share by Company in 2025
Figure 30. Neurological Biomarkers Revenue by Company in 2025 ($ millions)
Figure 31. Global Neurological Biomarkers Revenue Market Share by Company in 2025
Figure 32. Global Neurological Biomarkers Sales Market Share by Geographic Region (2020-2025)
Figure 33. Global Neurological Biomarkers Revenue Market Share by Geographic Region in 2025
Figure 34. Americas Neurological Biomarkers Sales 2020-2025 (K Units)
Figure 35. Americas Neurological Biomarkers Revenue 2020-2025 ($ millions)
Figure 36. APAC Neurological Biomarkers Sales 2020-2025 (K Units)
Figure 37. APAC Neurological Biomarkers Revenue 2020-2025 ($ millions)
Figure 38. Europe Neurological Biomarkers Sales 2020-2025 (K Units)
Figure 39. Europe Neurological Biomarkers Revenue 2020-2025 ($ millions)
Figure 40. Middle East & Africa Neurological Biomarkers Sales 2020-2025 (K Units)
Figure 41. Middle East & Africa Neurological Biomarkers Revenue 2020-2025 ($ millions)
Figure 42. Americas Neurological Biomarkers Sales Market Share by Country in 2025
Figure 43. Americas Neurological Biomarkers Revenue Market Share by Country (2020-2025)
Figure 44. Americas Neurological Biomarkers Sales Market Share byType (2020-2025)
Figure 45. Americas Neurological Biomarkers Sales Market Share by Application (2020-2025)
Figure 46. United States Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 47. Canada Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 48. Mexico Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 49. Brazil Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 50. APAC Neurological Biomarkers Sales Market Share by Region in 2025
Figure 51. APAC Neurological Biomarkers Revenue Market Share by Region (2020-2025)
Figure 52. APAC Neurological Biomarkers Sales Market Share byType (2020-2025)
Figure 53. APAC Neurological Biomarkers Sales Market Share by Application (2020-2025)
Figure 54. China Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 55. Japan Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 56. South Korea Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 57. Southeast Asia Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 58. India Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 59. Australia Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 60. ChinaTaiwan Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 61. Europe Neurological Biomarkers Sales Market Share by Country in 2025
Figure 62. Europe Neurological Biomarkers Revenue Market Share by Country (2020-2025)
Figure 63. Europe Neurological Biomarkers Sales Market Share byType (2020-2025)
Figure 64. Europe Neurological Biomarkers Sales Market Share by Application (2020-2025)
Figure 65. Germany Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 66.France Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 67. UK Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 68. Italy Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 69. Russia Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 70. Middle East & Africa Neurological Biomarkers Sales Market Share by Country (2020-2025)
Figure 71. Middle East & Africa Neurological Biomarkers Sales Market Share byType (2020-2025)
Figure 72. Middle East & Africa Neurological Biomarkers Sales Market Share by Application (2020-2025)
Figure 73. Egypt Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 74. South Africa Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 75. Israel Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 76.Turkey Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 77. GCC Countries Neurological Biomarkers Revenue Growth 2020-2025 ($ millions)
Figure 78. Manufacturing Cost Structure Analysis of Neurological Biomarkers in 2025
Figure 79. Manufacturing Process Analysis of Neurological Biomarkers
Figure 80. Industry Chain Structure of Neurological Biomarkers
Figure 81. Channels of Distribution
Figure 82. Global Neurological Biomarkers Sales MarketForecast by Region (2026-2031)
Figure 83. Global Neurological Biomarkers Revenue Market ShareForecast by Region (2026-2031)
Figure 84. Global Neurological Biomarkers Sales Market ShareForecast byType (2026-2031)
Figure 85. Global Neurological Biomarkers Revenue Market ShareForecast byType (2026-2031)
Figure 86. Global Neurological Biomarkers Sales Market ShareForecast by Application (2026-2031)
Figure 87. Global Neurological Biomarkers Revenue Market ShareForecast by Application (2026-2031)
